Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Analyze the trade-offs between Sp 500 ETFs and index funds in retirement strategies, focusing on costs, taxes, and simplicity.
25,310 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
Himax (HIMX) faces a pivotal year as AR/VR, automotive displays, and smartphone drivers shape demand. This Q1 2026 ea...
Trump heads Beijing high-stakes summit as markets watch for any change in US-China policy on crypto, potentially resh...
Opendoor's CEO recently bought 100,000 shares, signaling confidence to shareholders. This article breaks down what t...
SpaceX’s IPO filing reveals Elon Musk’s proposed package, a historic grant that vests only if the company reaches a $...
A single trading session can test even solid businesses. This article explains why autozone stock plummeting today ha...
A podcast recap attributes a Bezos stance to exempting the bottom half from federal income taxes, highlighting a broa...
As AI reshapes work, policymakers push for stable, simple tax rules rather than drastic overhauls. The debate feature...
Megapari unveils World Cup Pass 2026, offering three pass levels, free bets for task completion, and an automatic gra...
The Small Business Administration has paused new loans for green card holders, a policy shift that could disrupt immi...
U.S. stocks and futures react to a fresh batch of analyst calls on Dynatrace, Emerson Electric, Exxon Mobil and more....